CN102166311B - 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 - Google Patents
一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 Download PDFInfo
- Publication number
- CN102166311B CN102166311B CN2010105508229A CN201010550822A CN102166311B CN 102166311 B CN102166311 B CN 102166311B CN 2010105508229 A CN2010105508229 A CN 2010105508229A CN 201010550822 A CN201010550822 A CN 201010550822A CN 102166311 B CN102166311 B CN 102166311B
- Authority
- CN
- China
- Prior art keywords
- grams
- spleen
- radix
- hyperthyroidism
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 8
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 210000000952 spleen Anatomy 0.000 claims description 50
- 241000195474 Sargassum Species 0.000 claims description 9
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 8
- 241000244155 Taenia Species 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 5
- 201000010000 Agranulocytosis Diseases 0.000 abstract description 3
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 abstract description 3
- 229960002178 thiamazole Drugs 0.000 abstract description 3
- 210000003754 fetus Anatomy 0.000 abstract description 2
- 230000035935 pregnancy Effects 0.000 abstract description 2
- 210000004761 scalp Anatomy 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 240000004082 Bidens tripartita Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 244000025311 Calycanthus occidentalis Species 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 244000012254 Canarium album Species 0.000 abstract 1
- 235000009103 Canarium album Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000220457 Crotalaria Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000003208 anti-thyroid effect Effects 0.000 abstract 1
- 229940043671 antithyroid preparations Drugs 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008492 tangshen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 206010018498 Goitre Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 201000003872 goiter Diseases 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004090 etiopathogenesis Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009643 growth defect Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105508229A CN102166311B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105508229A CN102166311B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166311A CN102166311A (zh) | 2011-08-31 |
| CN102166311B true CN102166311B (zh) | 2012-03-07 |
Family
ID=44487754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105508229A Expired - Fee Related CN102166311B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166311B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705861B (zh) * | 2014-01-06 | 2016-01-27 | 河南中医学院 | 一种改善甲状腺癌术后气血亏虚证的中药 |
| WO2017152997A1 (en) | 2016-03-11 | 2017-09-14 | Volvo Truck Corporation | A method for operating an internal combustion piston engine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300623A (zh) * | 1999-12-20 | 2001-06-27 | 张发平 | 一种中成药 |
| CN1475229A (zh) * | 2002-08-14 | 2004-02-18 | 卫永生 | 抗疲劳复方中药方剂及其制备方法 |
| CN101085314A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经后期的中成药 |
-
2010
- 2010-11-19 CN CN2010105508229A patent/CN102166311B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300623A (zh) * | 1999-12-20 | 2001-06-27 | 张发平 | 一种中成药 |
| CN1475229A (zh) * | 2002-08-14 | 2004-02-18 | 卫永生 | 抗疲劳复方中药方剂及其制备方法 |
| CN101085314A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗月经后期的中成药 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166311A (zh) | 2011-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316208B (zh) | 具有补气养血、抗衰老、延年益寿的中药制剂 | |
| CN103610948B (zh) | 一种治疗高血压的中药组合物 | |
| CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
| CN1286518C (zh) | 一种治疗胃病的中药组合物 | |
| CN105381085A (zh) | 一种功能性中药枕 | |
| CN101934041A (zh) | 治疗胸膜炎的中草药 | |
| CN101376016B (zh) | 一种治疗高脂血症的中药制备方法 | |
| CN102166310B (zh) | 一种治疗肝肾阴虚型甲状腺功能亢进症的中药制备方法 | |
| CN105126043A (zh) | 一种治疗肝硬化的中药组合物及其用途 | |
| CN101912506A (zh) | 一种治疗慢性结肠炎的中药制剂 | |
| CN102166311B (zh) | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 | |
| CN102166309B (zh) | 一种治疗中焦蕴热型甲状腺功能亢进症的中药制备方法 | |
| CN104107352B (zh) | 一种降血压用中草药及其服用方法 | |
| CN102166326B (zh) | 一种治疗肝郁肾虚型甲状腺功能亢进症的中药制备方法 | |
| CN106177163A (zh) | 一种用于治疗瘙痒症的汤剂药物及其制备方法 | |
| CN105902872A (zh) | 一种治疗水肿的中药组合物 | |
| CN104857240A (zh) | 一种治疗慢性支气管炎的中药汤剂 | |
| CN102935214A (zh) | 一种治疗尿毒症的中药组合物 | |
| CN102166325B (zh) | 一种治疗甲状腺功能亢进症的中药制备方法 | |
| CN102058863B (zh) | 一种消除身体水肿的中药组合物 | |
| CN102166327B (zh) | 一种治疗肝郁脾虚型甲状腺功能亢进症的中药制备方法 | |
| CN105920440A (zh) | 一种治疗水肿的中药组合物 | |
| CN105148231A (zh) | 一种治疗胃溃疡的中药 | |
| CN105709176A (zh) | 一种治疗心血瘀阻型心悸的中药组合物及其制备方法 | |
| CN105687836A (zh) | 一种益气温阳消痹汤及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WU GUANGLONG Free format text: FORMER OWNER: LI DERU Effective date: 20111230 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wu Guanglong Inventor after: Song Ximin Inventor after: Wang Xiuyan Inventor before: Li Deru |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI DERU TO: WU GUANGLONG SONG XIMIN WANG XIUYAN Free format text: CORRECT: ADDRESS; FROM: 250061 JINAN, SHANDONG PROVINCE TO: 251507 DEZHOU, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20111230 Address after: The 251507 Hospital of Shandong province Dezhou City, Linyi County of Shengli Petroleum Administration Bureau Applicant after: Wu Guanglong Address before: 250061, No. 3, No. ten, No. 17531, 2-201, Shandong, Ji'nan Applicant before: Li Deru |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120307 Termination date: 20121119 |

